Filing Details
- Accession Number:
- 0001543407-13-000050
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-08-26 11:28:21
- Reporting Period:
- 2013-08-23
- Filing Date:
- 2013-08-26
- Accepted Time:
- 2013-08-26 11:28:21
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
10795 | Becton Dickinson & Co | BDX | Surgical & Medical Instruments & Apparatus (3841) | 220760120 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1221780 | L Bertram Scott | C/O Becton, Dickinson And Company 1 Becton Drive Franklin Lakes NJ 07417 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-08-23 | 2,276 | $49.05 | 22,655 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2013-08-23 | 2,160 | $57.21 | 24,815 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-08-23 | 4,047 | $98.61 | 20,768 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2013-08-23 | 2,276 | $0.00 | 2,276 | $49.05 |
Common Stock | Stock Option (right to buy) | Disposition | 2013-08-23 | 2,160 | $0.00 | 2,160 | $57.21 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2005-02-11 | 2014-02-11 | No | 4 | M | Direct |
0 | 2006-02-01 | 2015-02-01 | No | 4 | M | Direct |
Footnotes
- The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $98.57 through $98.66. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request.
- The option became exercisable in four annual installments beginning February 11, 2005.
- The option became exercisable in four annual installments beginning February 1, 2006.